Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2020
Headcount
6
HQ
—
Sector
Health Tech & Life Sciences
About
SuperSpectra develops a noninvasive imaging device for the early detection and degradation followup of Alzheimer's disease by measuring CSF A and tau quantitative results. The company offers a high-accuracy quantitative measurement with real-time imaging of biomarkers of Alzheimer's disease. This noninvasive direct CSF analysis is ionizing radiation free, pain free, and risk free. Tests can be performed daily/weekly.
Q&A
- What is SuperSpectra's primary focus?
- SuperSpectra develops a noninvasive imaging device for the early detection and degradation follow-up of Alzheimer's disease by measuring CSF A and tau quantitative results.
- What is the current status of SuperSpectra?
- SuperSpectra is currently inactive, having ceased to operate in September 2024.
- When was SuperSpectra founded?
- SuperSpectra was founded in May 2020.
- How many employees does SuperSpectra have?
- SuperSpectra has 6 employees, falling within the 1-10 employee bucket.
- Who are the co-founders of SuperSpectra?
- The co-founders of SuperSpectra are Yevgeny Beiderman (Co-founder & CEO) and Zeev Zalevsky (Co-founder & CTO).
- In which sector does SuperSpectra primarily operate?
- SuperSpectra's primary sector is Health Tech & Life Sciences.
- What is the product stage of SuperSpectra's offering?
- SuperSpectra's product is currently in the alpha stage.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Simulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B2C
Tags
non-invasiveearly-detectionmedical-devicesalzheimers-diseasespectroscopy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2020-5 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Sep 2024 ceased to operate |